Clinical trials for Ulcerative colitis (uc) investigate a range of treatment strategies and patient populations.

11 total trials for this combination

Showing top 10 of 11 trials

Trials

NCT ID	Title	Status	Phase
NCT01848561	A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)	ACTIVE_NOT_RECRUITING	—
NCT03398148	A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis	COMPLETED	PHASE2/PHASE3
NCT02819635	A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)	COMPLETED	PHASE2/PHASE3
NCT03398135	A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis	ACTIVE_NOT_RECRUITING	PHASE3
NCT03653026	A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis	COMPLETED	PHASE3
NCT07415044	LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis	RECRUITING	—
NCT02065622	Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis	COMPLETED	PHASE3
NCT07415044	LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis	RECRUITING	—
NCT03006068	A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)	ACTIVE_NOT_RECRUITING	PHASE3
NCT03695185	A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy	COMPLETED	PHASE2

Related Pages

All Ulcerative colitis (uc) trials All trials in Chicago, United States